| Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways B Singh, R Shoulson, A Chatterjee, A Ronghe, NK Bhat, DC Dim, HK Bhat Carcinogenesis 35 (8), 1872-1880, 2014 | 250 | 2014 |
| PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer VW Rebecca, MC Nicastri, C Fennelly, CI Chude, JS Barber-Rotenberg, ... Cancer discovery 9 (2), 220-229, 2019 | 199 | 2019 |
| MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis B Singh, AM Ronghe, A Chatterjee, NK Bhat, HK Bhat Carcinogenesis 34 (5), 1165-1172, 2013 | 198 | 2013 |
| A unified approach to targeting the lysosome's degradative and growth signaling roles VW Rebecca, MC Nicastri, N McLaughlin, C Fennelly, Q McAfee, ... Cancer discovery 7 (11), 1266-1283, 2017 | 167 | 2017 |
| Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer B Singh, A Chatterjee, AM Ronghe, NK Bhat, HK Bhat BMC cancer 13, 1-9, 2013 | 132 | 2013 |
| PPT1 inhibition enhances the antitumor activity of anti–PD-1 antibody in melanoma G Sharma, R Ojha, E Noguera-Ortega, VW Rebecca, J Attanasio, S Liu, ... JCI insight 5 (17), 2020 | 61 | 2020 |
| Novel Aza-resveratrol analogs: synthesis, characterization and anticancer activity against breast cancer cell lines A Siddiqui, P Dandawate, R Rub, S Padhye, S Aphale, A Moghe, ... Bioorganic & medicinal chemistry letters 23 (3), 635-640, 2013 | 48 | 2013 |
| Antioxidant activities of novel resveratrol analogs in breast cancer A Chatterjee, A Ronghe, SB Padhye, DA Spade, NK Bhat, HK Bhat Journal of biochemical and molecular toxicology 32 (1), e21925, 2018 | 36 | 2018 |
| Natural antioxidants exhibit chemopreventive characteristics through the regulation of CNC b‐Zip transcription factors in estrogen‐induced breast carcinogenesis A Chatterjee, A Ronghe, B Singh, NK Bhat, J Chen, HK Bhat Journal of biochemical and molecular toxicology 28 (12), 529-538, 2014 | 27 | 2014 |
| Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1, 2-diol}, a novel resveratrol analog A Ronghe, A Chatterjee, B Singh, P Dandawate, L Murphy, NK Bhat, ... The Journal of steroid biochemistry and molecular biology 144, 500-512, 2014 | 20 | 2014 |
| 4-(E)-{(p-tolylimino)-methylbenzene-1, 2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells A Ronghe, A Chatterjee, B Singh, P Dandawate, F Abdalla, NK Bhat, ... Toxicology and applied pharmacology 301, 1-13, 2016 | 16 | 2016 |
| {(4-hydroxyphenylimino)-methylbenzene, 1, 2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1, 2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast … A Ronghe, A Chatterjee, NK Bhat, S Padhye, HK Bhat Oncotarget 7 (32), 51747-51762, 2016 | 11 | 2016 |
| Tamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1, 2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1, 2-diol}, novel azaresveratrol analogs, in … A Ronghe, A Chatterjee, NK Bhat, S Padhye, HK Bhat Oncotarget 7 (32), 51747, 2016 | 9 | 2016 |
| Novel resveratrol-analog HPIMBD inhibits breast cancer cell metastasis by reversal of epithelial-mesenchymal transition A Chatterjee, A Ronghe, S Padhye, HK Bhat Cancer Research 75 (15_Supplement), 4650-4650, 2015 | 2 | 2015 |
| PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanoma. G Sharma, R Ojha, E Noguera-Ortega, VW Rebecca, J Attanasio, S Liu, ... JCI insight 7 (20), e165688-e165688, 2022 | 1 | 2022 |
| Differential regulation of estrogen metabolizing CYP1A1 and CYP1B1 enzymes by novel resveratrol analogs in breast cancer cells AM Ronghe, A Chatterjee, S Padhye, HK Bhat Cancer Research 75 (15_Supplement), 4648-4648, 2015 | 1 | 2015 |
| Corrigendum: PPT1 inhibition enhances the antitumor activity of anti–PD-1 antibody in melanoma (JCI Insight (2020) 5: 17 (e133225 G Sharma, R Ojha, E Noguera-Ortega, VW Rebecca, J Attanasio, S Liu, ... JCI Insight 7 (20), e165688, 2022 | | 2022 |
| Co-targeting BET and MEK as salvage therapy for MAPKi and checkpoint inhibitor resistant melanoma J Villanueva, IM Echevarria-Vargas, PI Reyes-Uribe, A Guterres, ... Cancer Research 79 (13_Supplement), 3842-3842, 2019 | | 2019 |
| Potential Mechanisms for Inhibition of Breast Cancer by Novel Azaresveratrol Analogs: Implications of Estrogen Receptor, Estrogen Metabolism and Cell Death Pathways AM Ronghe | | 2015 |
| Tamoxifen synergizes cytotoxic activity of 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1, 2-diol}(HPIMBD), a novel resveratrol analogue against breast cancer cells AM Ronghe, A Chatterjee, F Abdalla, HK Bhat Cancer Research 74 (19_Supplement), 1234-1234, 2014 | | 2014 |
anwesha chatterjeeResearch and Development Scientist, Sciegen Pharmaceuticals NY, USA; ADAMAS University, Kolkata在 uky.edu 的电子邮件经过验证
